Diabetes, Vol 34, Issue 11 1092-1103, Copyright © 1985 by American Diabetes Association

ARTICLES

Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements

M Ader, G Pacini, YJ Yang and RN Bergman

Glucose disappearance after an oral or intravenous challenge is a function of the effects of both endogenously secreted insulin and of glucose itself. We previously introduced the term "glucose effectiveness," or SG, defined as the ability of glucose per se to enhance its own disappearance independent of an increment in plasma insulin. The present investigation, performed in conscious dogs, was undertaken to quantify this glucose effect by minimal-model-based analysis of insulin and glucose dynamics after a frequently sampled intravenous glucose tolerance test (FSIGT). The values from the standard FSIGT were then compared with direct measurements obtained from experiments in which the dynamic insulin response to glucose was suppressed with somatostatin (SRIF). In addition, we examined SG values from the modified FSIGT protocol, which involves both glucose and tolbutamide injections. Protocol l (N = 9): FSIGTs were performed and the glucose and insulin data were analyzed by computer. KG was 2.65 +/- 0.28 min-1, S1 was 4.09 +/- 0.34 X 10(4) min-1/(microU/ml), and SG was 0.033 +/- 0.004 min-1. Protocol II (N = 6): FSIGTs were performed on animals in which SRIF was infused (0.8 micrograms/min X kg) to obliterate the dynamic insulin response to glucose injection. Before the FSIGt, insulin and glucagon were infused intraportally to reattain basal glycemia. Without dynamic insulin, KG was reduced to 0.96 +/- 0.18 min-1 (P less than 0.0001). However, SG, estimated from the exponential rate of fall of plasma glucose in the absence of dynamic insulin, was similar to the standard FSIGTs: 0.025 +/- 0.004 (P greater than 0.25). Protocol III (N = 6): modified FSIGTs were performed using glucose and tolbutamide injections for a better estimate of model parameters. Model parameters Sl and SG, and the KG were not different from standard FSIGTs (P greater than 0.3). In fact, the value of SG (0.028 +/- 0.003 min-1) was nearly identical to the direct measure from protocol II. Therefore, the effect of glucose per se on glucose decline, estimated by modeling the standard and modified FSIGTs, was confirmed by a direct measurement with the endogenous insulin response suppressed with SRIF. Also, the time course of the insulin effect to enhance net glucose disappearance from plasma [Ieff(t)] was calculated from the data of protocol II, and was the same as the time course predicted by the model. These studies demonstrate the ability of the computer modeling approach to separate insulin-dependent and glucose-dependent glucose disappearance, and represent a direct confirmation of the minimal model.(ABSTRACT TRUNCATED AT 400 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. T. Fueger, C. Y. Li, J. E. Ayala, J. Shearer, D. P. Bracy, M. J. Charron, J. N. Rottman, and D. H. Wasserman Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter J. Physiol., July 15, 2007; 582(2): 801 - 812. [Abstract] [Full Text] [PDF]

				K. Thomaseth, A. Pavan, G. Pacini, and B. Ahren Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1808 - E1814. [Abstract] [Full Text] [PDF]

				M. R. Rickels, A. Naji, and K. L. Teff Insulin Sensitivity, Glucose Effectiveness, and Free Fatty Acid Dynamics after Human Islet Transplantation for Type 1 Diabetes J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2138 - 2144. [Abstract] [Full Text] [PDF]

				Y. Hayashi, S. Nagasaka, N. Takahashi, I. Kusaka, S. Ishibashi, S. Numao, D. J. Lee, Y. Taki, H. Ogata, K. Tokuyama, et al. A Single Bout of Exercise at Higher Intensity Enhances Glucose Effectiveness in Sedentary Men J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4035 - 4040. [Abstract] [Full Text] [PDF]

				K. M. Krudys, M. G. Dodds, S. M. Nissen, and P. Vicini Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1038 - E1046. [Abstract] [Full Text] [PDF]

				F. Brandou, J.-F. Brun, and J. Mercier Limited Accuracy of Surrogates of Insulin Resistance during Puberty in Obese and Lean Children at Risk for Altered Glucoregulation J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 761 - 767. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				Y. Nishida, K. Tokuyama, S. Nagasaka, Y. Higaki, Y. Shirai, A. Kiyonaga, M. Shindo, I. Kusaka, T. Nakamura, S. Ishibashi, et al. Effect of Moderate Exercise Training on Peripheral Glucose Effectiveness, Insulin Sensitivity, and Endogenous Glucose Production in Healthy Humans Estimated by a Two-Compartment-Labeled Minimal Model Diabetes, February 1, 2004; 53(2): 315 - 320. [Abstract] [Full Text]

				T. A. Gresl, R. J. Colman, T. C. Havighurst, L. O. Byerley, D. B. Allison, D. A. Schoeller, and J. W. Kemnitz Insulin sensitivity and glucose effectiveness from three minimal models: effects of energy restriction and body fat in adult male rhesus monkeys Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1340 - R1354. [Abstract] [Full Text] [PDF]

				H. Stingl, W. J. Schnedl, M. Krssak, E. Bernroider, M. G. Bischof, T. Lahousen, G. Pacini, and M. Roden Reduction of Hepatic Glycogen Synthesis and Breakdown in Patients with Agenesis of the Dorsal Pancreas J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4678 - 4685. [Abstract] [Full Text] [PDF]

				K. Persson, G. Pacini, F. Sundler, and B. Ahren Islet Function Phenotype in Gastrin-Releasing Peptide Receptor Gene-Deficient Mice Endocrinology, October 1, 2002; 143(10): 3717 - 3726. [Abstract] [Full Text] [PDF]

				B. Ahren and G. Pacini Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E738 - E744. [Abstract] [Full Text] [PDF]

				Y. Nishida, K. Tokuyama, S. Nagasaka, Y. Higaki, K. Fujimi, A. Kiyonaga, M. Shindo, I. Kusaka, T. Nakamura, S.-E Ishikawa, et al. SG, SI, and EGP of exercise-trained middle-aged men estimated by a two-compartment labeled minimal model Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E809 - E816. [Abstract] [Full Text] [PDF]

				G. Pacini, K. Thomaseth, and B. Ahren Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E693 - E703. [Abstract] [Full Text] [PDF]

				K. Sjogren, K. Wallenius, J.-L. Liu, M. Bohlooly-Y, G. Pacini, L. Svensson, J. Tornell, O. G.P. Isaksson, B. Ahren, J.-O. Jansson, et al. Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism Diabetes, July 1, 2001; 50(7): 1539 - 1545. [Abstract] [Full Text] [PDF]

				Y. Nishida, Y. Higaki, K. Tokuyama, K. Fujimi, A. Kiyonaga, M. Shindo, Y. Sato, and H. Tanaka Effect of Mild Exercise Training on Glucose Effectiveness in Healthy Men Diabetes Care, June 1, 2001; 24(6): 1008 - 1013. [Abstract] [Full Text]

				C. McDonald, A. Dunaif, and D. T. Finegood Minimal-Model Estimates of Insulin Sensitivity Are Insensitive to Errors in Glucose Effectiveness J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2504 - 2508. [Abstract] [Full Text]

				M. Sakamoto, Y. Higaki, Y. Nishida, A. Kiyonaga, M. Shindo, K. Tokuyama, and H. Tanaka Influence of mild exercise at the lactate threshold on glucose effectiveness J Appl Physiol, December 1, 1999; 87(6): 2305 - 2310. [Abstract] [Full Text] [PDF]

				B. Ahren and G. Pacini Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E996 - E1004. [Abstract] [Full Text] [PDF]

				R. Basu, A. Basu, M. Nielsen, P. Shah, and R. A. Rizza Effect of Overnight Restoration of Euglycemia on Glucose Effectiveness in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2314 - 2319. [Abstract] [Full Text]

				A. Caumo, P. Vicini, J. J. Zachwieja, A. Avogaro, K. Yarasheski, D. M. Bier, and C. Cobelli Undermodeling affects minimal model indexes: insights from a two-compartment model Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1171 - E1193. [Abstract] [Full Text] [PDF]

				M. D. McArthur, D. You, K. Klapstein, and D. T. Finegood Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E739 - E746. [Abstract] [Full Text] [PDF]

				K. Filipsson, G. Pacini, A. J. W. Scheurink, and B. Ahren PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E834 - E842. [Abstract] [Full Text] [PDF]

				G. Pacini, G. Tonolo, M. Sambataro, M. Maioli, M. Ciccarese, E. Brocco, A. Avogaro, and R. Nosadini Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E592 - E599. [Abstract] [Full Text] [PDF]

				A. Caumo, C. Cobelli;, and D. T. Finegood Letters to the Editor Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E573 - E576. [Abstract] [Full Text] [PDF]

				K. Izumino, H. Sakamaki, M. Ishibashi, H. Takino, H. Yamasaki, Y. Yamaguchi, N. Chikuba, K. Matsumoto, S. Akazawa, K. Tokuyama, et al. Troglitazone Ameliorates Insulin Resistance in Patients with Werner's Syndrome J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2391 - 2395. [Abstract] [Full Text] [PDF]